Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06526065
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
Sponsor: University Medical Center Goettingen
View on ClinicalTrials.gov
Summary
The trial aims at the construction and validation of an accurate, affordable and simple prognostic tool to be used in everyday clinical practice, which allows the early and reliable identification of DLBCL patients who have a very high risk of treatment failure following R-CHOP/-like first-line therapy.
Official title: Molecular Mechanisms in Malignant Lymphoma- Predict
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-06-20
Completion Date
2029-06-01
Last Updated
2024-07-29
Healthy Volunteers
No
Conditions
Interventions
OTHER
no intervention
no intervention
Locations (1)
Universitätsmedizin Göttingen
Göttingen, Lower Saxony, Germany